author-photo

Ernesto Aycardi

Merck Serono

32

Papers

763

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study.

2021 Headache
Show All
- Source
- Cite
- Save
Citations (1)
Clinical Characteristics and Treatment Experience of Individuals with SCN8A Developmental and Epileptic Encephalopathy (SCN8A-DEE): Findings from an Online Caregiver Survey

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (0)
An Online Survey of Caregivers of Patients with KCNQ2 Developmental & Epileptic Encephalopathy (KCNQ2-DEE) (4775)

2020 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of Two Formulations of a Novel Nav1.6 Sodium Channnel Blocker (XEN901) in Healthy Adult Subjects. (4757)

2020 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Reliable Count of Seizures using Diaries versus Video Electroencephalography for Seizures of KCNQ2-DEE (4934)

2020 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials:

2019 Cephalalgia
Show All
- Source
- Cite
- Save
Citations (19)
Fremanezumab Cardiovascular and Cerebrovascular Safety Profile: Pooled Data From Placebo-Controlled and Long-Term Studies (S17.005)

2019 Neurology
Show All
- Source
- Cite
- Save
Citations (2)
The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post‐Hoc Analyses on the First 3 Weeks of Treatment

2019 Headache
Show All
- Source
- Cite
- Save
Citations (21)
Efficacy of Fremanezumab in Patients With Chronic Migraine Who Had Prior Use of Topiramate or OnabotulinumtoxinA (P4.104)

2018 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
From LBR-101 to Fremanezumab for Migraine

2018 CNS Drugs
Show All
- Source
- Cite
- Save
Citations (11)